Bank of New York Mellon’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $69M | Sell |
128,520
-7,388
| -5% | -$3.78M | 0.01% | 865 |
|
|
2026
Q1 | $71.1M | Sell |
135,908
-961
| -0.7% | -$459K | 0.01% | 798 |
|
|
2025
Q4 | $79.7M | Buy |
136,869
+39,090
| +40% | +$20M | 0.01% | 759 |
|
|
2025
Q3 | $44.8M | Buy |
97,779
+8,836
| +10% | +$3.3M | 0.01% | 1092 |
|
|
2025
Q2 | $26.9M | Buy |
88,943
+28,154
| +46% | +$8.39M | 0.01% | 1361 |
|
|
2025
Q1 | $20.1M | Buy |
60,789
+579
| +1% | +$190K | ﹤0.01% | 1506 |
|
|
2024
Q4 | $18.6M | Sell |
60,210
-151
| -0.3% | -$42.5K | ﹤0.01% | 1610 |
|
|
2024
Q3 | $12.8M | Sell |
60,361
-13,454
| -18% | -$3.44M | ﹤0.01% | 1808 |
|
|
2024
Q2 | $20.7M | Buy |
73,815
+15,932
| +28% | +$3.79M | ﹤0.01% | 1559 |
|
|
2024
Q1 | $15.5M | Sell |
57,883
-4,295
| -7% | -$1.01M | ﹤0.01% | 1725 |
|
|
2023
Q4 | $14.4M | Buy |
62,178
+3,392
| +6% | +$594K | ﹤0.01% | 1778 |
|
|
2023
Q3 | $8.59M | Buy |
58,786
+2,288
| +4% | +$431K | ﹤0.01% | 2032 |
|
|
2023
Q2 | $13.1M | Buy |
56,498
+12,736
| +29% | +$3.45M | ﹤0.01% | 1800 |
|
|
2023
Q1 | $10.6M | Buy |
43,762
+791
| +2% | +$216K | ﹤0.01% | 1912 |
|
|
2022
Q4 | $12.5M | Buy |
42,971
+2,269
| +6% | +$222K | ﹤0.01% | 1820 |
|
|
2022
Q3 | $2.65M | Buy |
40,702
+4,208
| +12% | +$292K | ﹤0.01% | 2654 |
|
|
2022
Q2 | $2.61M | Buy |
36,494
+367
| +1% | +$27K | ﹤0.01% | 2676 |
|
|
2022
Q1 | $3.54M | Buy |
36,127
+1,383
| +4% | +$117K | ﹤0.01% | 2605 |
|
|
2021
Q4 | $2.94M | Sell |
34,744
-9,953
| -22% | -$818K | ﹤0.01% | 2756 |
|
|
2021
Q3 | $3.57M | Buy |
44,697
+4,887
| +12% | +$422K | ﹤0.01% | 2661 |
|
|
2021
Q2 | $3.88M | Buy |
39,810
+4,983
| +14% | +$590K | ﹤0.01% | 2616 |
|
|
2021
Q1 | $4.07M | Sell |
34,827
-679
| -2% | -$79.2K | ﹤0.01% | 2537 |
|
|
2020
Q4 | $3.95M | Sell |
35,506
-714
| -2% | -$87.3K | ﹤0.01% | 2468 |
|
|
2020
Q3 | $4.3M | Sell |
36,220
-826
| -2% | -$89.7K | ﹤0.01% | 2299 |
|
|
2020
Q2 | $4.2M | Buy |
37,046
+1,183
| +3% | +$116K | ﹤0.01% | 2294 |
|
|
2020
Q1 | $2.39M | Buy |
35,863
+1,689
| +5% | +$141K | ﹤0.01% | 2464 |
|
|
2019
Q4 | $3.11M | Buy |
34,174
+1,679
| +5% | +$163K | ﹤0.01% | 2580 |
|
|
2019
Q3 | $2.8M | Buy |
32,495
+358
| +1% | +$33.6K | ﹤0.01% | 2566 |
|
|
2019
Q2 | $3.37M | Buy |
32,137
+1,355
| +4% | +$145K | ﹤0.01% | 2525 |
|
|
2019
Q1 | $3.86M | Sell |
30,782
-33
| -0.1% | -$4.1K | ﹤0.01% | 2454 |
|
|
2018
Q4 | $3.47M | Sell |
30,815
-6,670
| -18% | -$1.03M | ﹤0.01% | 2476 |
|
|
2018
Q3 | $8.03M | Buy |
37,485
+2,950
| +9% | +$740K | ﹤0.01% | 2153 |
|
|
2018
Q2 | $9.66M | Buy |
34,535
+3,387
| +11% | +$595K | ﹤0.01% | 2041 |
|
|
2018
Q1 | $3.64M | Buy |
31,148
+270
| +0.9% | +$33.3K | ﹤0.01% | 2507 |
|
|
2017
Q4 | $2.83M | Buy |
30,878
+17,933
| +139% | +$1.02M | ﹤0.01% | 2648 |
|
|
2017
Q3 | $582K | Buy |
12,945
+1,963
| +18% | +$36.7K | ﹤0.01% | 3514 |
|
|
2017
Q2 | $179K | Buy |
+10,982
| New | +$172K | ﹤0.01% | 3925 |
|
|
2016
Q3 | – | Sell |
-4,400
| Closed | -$40K | – | 4300 |
|
|
2016
Q2 | $40K | Sell |
4,400
-9,641
| -69% | -$116K | ﹤0.01% | 4214 |
|
|
2016
Q1 | $118K | Buy |
14,041
+28
| +0.2% | +$234 | ﹤0.01% | 3930 |
|
|
2015
Q4 | $173K | Sell |
14,013
-2,010
| -13% | -$55.2K | ﹤0.01% | 3909 |
|
|
2015
Q3 | $976K | Sell |
16,023
-4,320
| -21% | -$312K | ﹤0.01% | 3202 |
|
|
2015
Q2 | $1.59M | Buy |
20,343
+4,597
| +29% | +$386K | ﹤0.01% | 3068 |
|
|
2015
Q1 | $1.07M | Buy |
15,746
+3,114
| +25% | +$267K | ﹤0.01% | 3269 |
|
|
2014
Q4 | $1.17M | Sell |
12,632
-2,728
| -18% | -$282K | ﹤0.01% | 3212 |
|
|
2014
Q3 | $1.62M | Buy |
15,360
+6,079
| +65% | +$846K | ﹤0.01% | 3021 |
|
|
2014
Q2 | $1.33M | Buy |
9,281
+813
| +10% | +$119K | ﹤0.01% | 3149 |
|
|
2014
Q1 | $1.28M | Buy |
8,468
+644
| +8% | +$127K | ﹤0.01% | 3164 |
|
|
2013
Q4 | $1.44M | Buy |
7,824
+627
| +9% | +$115K | ﹤0.01% | 3086 |
|
|
2013
Q3 | $1.59M | Buy |
7,197
+863
| +14% | +$184K | ﹤0.01% | 2990 |
|
|
2013
Q2 | $1.11M | Buy |
+6,334
| New | +$1.65M | ﹤0.01% | 3137 |
|
Other funds holding MDGL
EAM
EAM
Bank of New York Mellon's MDGL Position: Q2 2026 in Review
Bank of New York Mellon reduced its Madrigal Pharmaceuticals (MDGL) stake by 5.4% in Q2 2026, selling an estimated $3.78M and leaving 128,520 shares worth $69M. The position accounts for 0.01% of the portfolio, ranked #865.
Bank of New York Mellon first reported a position in MDGL in Q2 2013 and has held it in 50 quarters since. The position peaked at $79.7M in Q4 2025. 174 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.
- Bank of New York Mellon held 128,520 shares of Madrigal Pharmaceuticals worth $69M as of Q2 2026.
- Bank of New York Mellon sold 7,388 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $3.78M.
- Madrigal Pharmaceuticals made up 0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #865 holding.
- Bank of New York Mellon first reported a position in Madrigal Pharmaceuticals in Q2 2013 and has held it in 50 quarters since.
- Bank of New York Mellon's Madrigal Pharmaceuticals position peaked at $79.7M in Q4 2025.
- 174 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.